First Ascent Biomedical Announces Innovation Collaborative With Lucem Health™ to Help Bring AI/ML to the Front Lines of Healthcare finance.yahoo.com/news/first-asc… via Yahoo Finance

linkedin.com/posts/activity…

Thanks for the info. Good to know that buying a glorified golf cart will magically stop the shifting of tectonic plates in the earth's crust. (These people vote).

Researchers at FIU and firstascentbio have used an artificial intelligence-powered, functional precision medicine platform to identify unique therapeutic treatment options for children with relapsed cancer diagnoses. Learn more: ow.ly/7yEr50Rfnwv

An FPM approach to treating cancer is the future! The future is now. What was previously unattainable is now a reality combining biology and technology.

Exciting progress in precision medicine! Functional and genomic approaches are converging to better match cancer patients with personalized therapies. The future of oncology is here. Read more: ascopost.com/issues/novembe… #PrecisionMedicine #CancerResearch"

Last week at FIU, Ron DeSantis announced $2 million in funding from the Casey DeSantis Florida Cancer Innovation Fund to expand patient access in personalized cancer treatment technologies! The grant supports firstascentbio First Ascent Biomedical, co-founded by

Thank you Ron DeSantis and his wife, Casey DeSantis, for awarding First Ascent a $2 million grant from the Florida Dept. of Health Florida Cancer Innovation Fund to support our AI-powered xDRIVE Drug Prediction Platform. Our technology will provide access to faster, personalized

We are grateful for the collaboration opportunities with CancerX as we push forward in the fight against cancer. A huge thank you to the Champions we’re working with - Moffitt Cancer Center, Advocate Health Care, Johnson & Johnson Innovation, CEI Ventures, and KidsX - for driving innovation

BIG NEWS: We are advancing PERSONALIZED TREATMENT for CRC patients. We’re teaming up with Jim Foote, CEO of First Ascent Biomedical, to work on a powerful new approach to treating colorectal cancer, one that’s tailored to the individual.